Annual report
6856.TEDINET S100QGCM
Period2022-01-01 → 2022-12-31
Filed2023-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥270.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥224.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales |
| Revenue | ¥187.1bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥200.2bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥210.6bn | 2018-01-01 → 2018-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥45.8bn | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥32.0bn | 2021-01-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥46.9bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥32.0bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥19.4bn | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥20.5bn | 2019-01-01 → 2019-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥28.3bn | 2018-01-01 → 2018-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥47.3bn | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥30.2bn | 2021-01-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥34.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.3bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥13.2bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥15.5bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥22.3bn | 2018-01-01 → 2018-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥34.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥21.3bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥416.7bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥371.6bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥328.1bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥315.1bn | at 2019-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥277.4bn | at 2018-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥175.9bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥167.1bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥240.8bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥204.5bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥178.7bn | at 2020-12-31d | Cons. | Net assets |
| Net assets / equity | ¥171.6bn | at 2019-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥162.0bn | at 2018-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥139.9bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥135.0bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥138.8bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥133.9bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥114.2bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥96.1bn | at 2019-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥62.8bn | at 2018-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥34.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥32.3bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥26.6bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥19.5bn | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥10.7bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥14.7bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥14.0bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥12.4bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥11.0bn | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥22.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥843m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥19.2bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.2bn | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥807.06 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥505.05 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥312.58 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥367.09 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥529.24 | 2018-01-01 → 2018-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥802.89 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥502.46 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥311.09 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥365.44 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥526.98 | 2018-01-01 → 2018-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥5,684.68 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,827.06 | at 2021-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,217.45 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,053.3 | at 2019-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,826.44 | at 2018-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 57.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.8% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.3% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.3% | at 2019-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.2% | at 2018-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 15.4% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2021-01-01 → 2021-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.3% | 2018-01-01 → 2018-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 8,432 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 8,205 | at 2021-12-31 | Cons. | Number of employees |
| Employees | 8,269 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 8,288 | at 2019-12-31d | Cons. | Number of employees |
| Employees | 7,943 | at 2018-12-31d | Cons. | Number of employees |
| Revenue | ¥51.9bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥50.0bn | 2021-01-01 → 2021-12-31 | Standalone | Net sales |
| Revenue | ¥50.1bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥64.0bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥63.7bn | 2018-01-01 → 2018-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥3.8bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | ¥2.3bn | 2021-01-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | ¥16.0bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.7bn | 2021-01-01 → 2021-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥8.2bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.7bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.5bn | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥15.8bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.6bn | 2021-01-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | ¥14.6bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥1.9bn | 2021-01-01 → 2021-12-31 | Standalone | Profit loss |
| Net income | ¥7.3bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥11.8bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥12.1bn | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥223.0bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥221.8bn | at 2021-12-31 | Standalone | Assets |
| Total assets | ¥214.2bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥207.5bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥172.1bn | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥103.4bn | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥108.5bn | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥119.7bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥113.2bn | at 2021-12-31 | Standalone | Net assets |
| Net assets / equity | ¥114.7bn | at 2020-12-31d | Standalone | Net assets |
| Net assets / equity | ¥111.9bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥104.7bn | at 2018-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥52.9bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥62.6bn | at 2021-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥344.94 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.03 | 2021-01-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.02 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥280.18 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥286.03 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥343.16 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥44.8 | 2021-01-01 → 2021-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥171.2 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥278.92 | 2019-01-01 → 2019-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥284.81 | 2018-01-01 → 2018-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥245 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥150 | 2021-01-01 → 2021-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥130 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥145 | 2018-01-01 → 2018-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,815.8 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,664.43 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,700.73 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,638.66 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,468.74 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 53.3% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.7% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.2% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.6% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.5% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.6% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.7% | 2021-01-01 → 2021-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.0% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2018-01-01 → 2018-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 42,532,000 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,484 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 1,542 | at 2021-12-31 | Standalone | Number of employees |
| Employees | 1,623 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 1,702 | at 2019-12-31d | Standalone | Number of employees |
| Employees | 1,656 | at 2018-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 72
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥155.6bn |
| Automotive Test Systemsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥5.5bn |
| Automotive Test Systemsreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥3.9bn |
| Automotive Test Systemsreportable segment | employees | at 2022-12-31 | 2569 pure |
| Automotive Test Systemsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥67.5bn |
| Automotive Test Systemsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥67.5bn |
| Automotive Test Systemsreportable segment | segment assets | at 2022-12-31 | ¥84.2bn |
| Automotive Test Systemsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥667m |
| Medical Diagnostic Instruments And Systemsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥1.6bn |
| Medical Diagnostic Instruments And Systemsreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥2.0bn |
| Medical Diagnostic Instruments And Systemsreportable segment | employees | at 2022-12-31 | 1230 pure |
| Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥29.8bn |
| Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥29.8bn |
| Medical Diagnostic Instruments And Systemsreportable segment | segment assets | at 2022-12-31 | ¥28.5bn |
| Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥99m |
| Process And Environmental Instruments And Systemsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥829m |
| Process And Environmental Instruments And Systemsreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥727m |
| Process And Environmental Instruments And Systemsreportable segment | employees | at 2022-12-31 | 627 pure |
| Process And Environmental Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥22.5bn |
| Process And Environmental Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥22.5bn |
| Process And Environmental Instruments And Systemsreportable segment | segment assets | at 2022-12-31 | ¥19.7bn |
| Process And Environmental Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥2.1bn |
| Scientific Instruments And Systemsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥1.3bn |
| Scientific Instruments And Systemsreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥1.2bn |
| Scientific Instruments And Systemsreportable segment | employees | at 2022-12-31 | 1037 pure |
| Scientific Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥36.2bn |
| Scientific Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥36.2bn |
| Scientific Instruments And Systemsreportable segment | segment assets | at 2022-12-31 | ¥31.2bn |
| Scientific Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥2.5bn |
| Semiconductor Instruments And Systemsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥3.3bn |
| Semiconductor Instruments And Systemsreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥3.0bn |
| Semiconductor Instruments And Systemsreportable segment | employees | at 2022-12-31 | 1257 pure |
| Semiconductor Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥114.1bn |
| Semiconductor Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥114.1bn |
| Semiconductor Instruments And Systemsreportable segment | segment assets | at 2022-12-31 | ¥97.5bn |
| Semiconductor Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥42.0bn |
| Reconciling Itemsreconciling | segment assets | at 2021-12-31 | ¥153.3bn |
| Automotive Test Systemsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥5.5bn |
| Automotive Test Systemsreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥3.9bn |
| Automotive Test Systemsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥61.2bn |
| Automotive Test Systemsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥61.2bn |
| Automotive Test Systemsreportable segment | segment assets | at 2021-12-31 | ¥77.9bn |
| Automotive Test Systemsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | −¥13m |
| Medical Diagnostic Instruments And Systemsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥1.2bn |
| Medical Diagnostic Instruments And Systemsreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥1.8bn |
| Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥25.9bn |
| Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥25.9bn |
| Medical Diagnostic Instruments And Systemsreportable segment | segment assets | at 2021-12-31 | ¥24.4bn |
| Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥148m |
| Process And Environmental Instruments And Systemsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥982m |
| Process And Environmental Instruments And Systemsreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥747m |
| Process And Environmental Instruments And Systemsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥20.2bn |
| Process And Environmental Instruments And Systemsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥20.2bn |
| Process And Environmental Instruments And Systemsreportable segment | segment assets | at 2021-12-31 | ¥18.4bn |
| Process And Environmental Instruments And Systemsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥1.9bn |
| Scientific Instruments And Systemsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥877m |
| Scientific Instruments And Systemsreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥1.1bn |
| Scientific Instruments And Systemsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥30.0bn |
| Scientific Instruments And Systemsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥30.0bn |
| Scientific Instruments And Systemsreportable segment | segment assets | at 2021-12-31 | ¥25.3bn |
| Scientific Instruments And Systemsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥2.0bn |
| Semiconductor Instruments And Systemsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥3.9bn |
| Semiconductor Instruments And Systemsreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥2.6bn |
| Semiconductor Instruments And Systemsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥87.0bn |
| Semiconductor Instruments And Systemsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥87.0bn |
| Semiconductor Instruments And Systemsreportable segment | segment assets | at 2021-12-31 | ¥72.3bn |
| Semiconductor Instruments And Systemsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥28.0bn |
| Automotive Test Systemsreportable segment | employees | at 2022-12-31 | 391 pure |
| Medical Diagnostic Instruments And Systemsreportable segment | employees | at 2022-12-31 | 137 pure |
| Process And Environmental Instruments And Systemsreportable segment | employees | at 2022-12-31 | 138 pure |
| Scientific Instruments And Systemsreportable segment | employees | at 2022-12-31 | 125 pure |
| Semiconductor Instruments And Systemsreportable segment | employees | at 2022-12-31 | 32 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,777
| Item | Context | Value | Unit |
|---|---|---|---|
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 0.822 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 0.947 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 0.993 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.096 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.041 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01901-000AutomotiveTestSystemsReportableSegmentsMember | 2569 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01901-000ProcessAndEnvironmentalInstrumentsAndSystemsReportableSegmentsMember | 627 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01901-000MedicalDiagnosticInstrumentsAndSystemsReportableSegmentsMember | 1230 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01901-000SemiconductorInstrumentsAndSystemsReportableSegmentsMember | 1257 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01901-000ScientificInstrumentsAndSystemsReportableSegmentsMember | 1037 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 1712 | |
| Number of employees | CurrentYearInstant | 8432 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 1484 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 42.0 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 15.7 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 6564332 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01901-000AutomotiveTestSystemsReportableSegmentsMember | 391 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01901-000ProcessAndEnvironmentalInstrumentsAndSystemsReportableSegmentsMember | 138 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01901-000MedicalDiagnosticInstrumentsAndSystemsReportableSegmentsMember | 137 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01901-000SemiconductorInstrumentsAndSystemsReportableSegmentsMember | 32 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01901-000ScientificInstrumentsAndSystemsReportableSegmentsMember | 125 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 661 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 1484 | |
| Research and development expenses research and development activities | CurrentYearDuration | 18585000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E01901-000AutomotiveTestSystemsReportableSegmentsMember | 4848000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E01901-000ProcessAndEnvironmentalInstrumentsAndSystemsReportableSegmentsMember | 1893000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E01901-000MedicalDiagnosticInstrumentsAndSystemsReportableSegmentsMember | 2941000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E01901-000SemiconductorInstrumentsAndSystemsReportableSegmentsMember | 4998000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E01901-000ScientificInstrumentsAndSystemsReportableSegmentsMember | 3904000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 12565000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01901-000AutomotiveTestSystemsReportableSegmentsMember | 5509000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01901-000ProcessAndEnvironmentalInstrumentsAndSystemsReportableSegmentsMember | 829000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01901-000MedicalDiagnosticInstrumentsAndSystemsReportableSegmentsMember | 1624000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01901-000SemiconductorInstrumentsAndSystemsReportableSegmentsMember | 3285000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01901-000ScientificInstrumentsAndSystemsReportableSegmentsMember | 1316000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 42532752 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 42532752 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 42532752 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 42532752 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 58 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 36 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 176 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 332 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 17 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 7230 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 7849 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 152174 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |